The news headline from Denmark seems unexpected. The science behind it is not. Researchers have spent nearly a decade proving that tattoo ink does more than just color the skin, and the latest twin study comes at the end of a long line of evidence that began with a beam of X-rays.
Opening in Grenoble
In 2017, scientists from the European Synchrotron Radiation Facility in France did something that no one had achieved before. They tracked tattoo pigment inside human tissue, atom by atom.
Working with researchers from the German Federal Institute for Risk Assessment, the team used X-ray fluorescence to examine the skin and lymph nodes of four donor bodies. They confirmed that ink particles travel from the injection site and settle in the lymph nodes, where the body filters waste and strengthens immune defenses.
The particles arrived in two sizes. Larger pigment fragments remained in the skin. Smaller fragments, some measuring less than 100 nanometers across, entered the lymphatic system and remained there.
This study answered one question and raised a more complex one. Now scientists knew where the ink went. They didn’t know what he did when he arrived.
From mechanism to population
Proving that the pigment reaches the lymph nodes is one thing. Proving that this increases the risk of cancer in a population requires many more people and much more time.
In 2024, researchers at Lund University in Sweden published one of the first major attempts. They compared cases of lymphoma with controls and found a modest increase in risk among tattooed people, especially for diffuse large B-cell lymphoma.
That same year, a team from the University of Utah studied the link between tattoos and blood cancer, studying 820 cases and more than 8,000 controls. This work added a chemical dimension to the conversation. Commercial inks may contain heavy metals and compounds that the International Agency for Research on Cancer classifies as carcinogenic or possibly carcinogenic.
Each study had its own limitations and uncertainties. Together, they moved the issue from the laboratory bench to public health.
Double advantage
The newest entry comes from the University of Southern Denmark and the University of Helsinki and was published in January 2025. Its central instrument was the Danish Tattooed Twins Cohort, a survey of Danish twins collected in 2021.
Twins give researchers the opportunity to separate the influence of tattoos from the influence of genes and general upbringing. When one twin has a tattoo and the other doesn’t, the comparison removes much of the noise that confounds other studies.
The team analyzed a cohort of 2,367 twins and a separate case-control cohort of 316 twins recruited from this study. They linked each person to the Danish Cancer Registry to track diagnoses over time.
Tattooed people had higher rates of skin cancer and lymphoma than people without ink.
Size and timing matter
The size of the tattoo changed the picture. People with tattoos larger than the palm of their hand are about 2.7 times more likely to develop lymphoma than people without tattoos. The figures for skin cancer followed a similar pattern.
The researchers believe this gradient is a clue to the mechanism. A larger tattoo that lasts longer deposits more pigment in the lymph nodes.
“This suggests that the larger the tattoo and the longer it is there, the more ink accumulates in the lymph nodes,” said Signe Bedsted Clemmensen, assistant professor of biostatistics at the University of Southern Denmark.
What the numbers can’t tell you yet
Each command in this line emphasizes the same caution. These studies show an association, not proof of cause. Cancer develops slowly, often over decades, making it difficult to measure the true long-term effect in people who only recently started getting tattoos.
The stakes are not small. According to the Pew Research Center, about a third of U.S. adults have at least one tattoo, and among adults under age 30, the proportion exceeds 40 percent. A risk factor that affects so many people deserves a clear answer.
Now the work moves to the cellular level, where researchers hope to learn what effect the pigment actually has on immune tissue throughout life. The synchrotron showed where the ink was. The next decade may finally show what it’s worth.
The full version of the study was published in the journal BMC Public Health.
—
Like what you’re reading? Subscribe to our newsletter to receive interesting articles, exclusive content and the latest updates.
Visit us at EarthSnap, a free app created by Eric Ralls and Earth.com.
——